Michael Nauck

Michael Nauck

UNVERIFIED PROFILE

Are you Michael Nauck?   Register this Author

Register author
Michael Nauck

Michael Nauck

Publications by authors named "Michael Nauck"

Are you Michael Nauck?   Register this Author

100Publications

2406Reads

7Profile Views

Importance of localization of insulinomas: a systematic analysis.

J Hepatobiliary Pancreat Sci 2019 Sep 16;26(9):383-392. Epub 2019 Jul 16.

Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jhbp.642DOI Listing
September 2019

Effect of portal glucose sensing on incretin hormone secretion in a canine model.

Am J Physiol Endocrinol Metab 2019 Aug 21;317(2):E244-E249. Epub 2019 May 21.

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine , Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpendo.00100.2019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732466PMC
August 2019

Longitudinal changes in fasting and glucose-stimulated GLP-1 and GIP in healthy older subjects.

J Clin Endocrinol Metab 2019 Aug 8. Epub 2019 Aug 8.

NHMRC Centre of Research Excellence in Translating Nutritional Science to Good Health, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2019-01262DOI Listing
August 2019

Clinical Predictors of the Need for Further Treatment Escalation in Patients with Type 2 Diabetes on Basal Insulin Therapy - A Retrospective Observational Study.

Exp Clin Endocrinol Diabetes 2019 Aug 14. Epub 2019 Aug 14.

Diabetes Center Bad Lauterberg, Bad Lauterberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0972-9700DOI Listing
August 2019

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.

Lancet 2019 07 8;394(10192):39-50. Epub 2019 Jun 8.

Diabetes Division, Department of Medicine I, St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31271-1DOI Listing
July 2019

Pioneering oral peptide therapy for patients with type 2 diabetes.

Lancet Diabetes Endocrinol 2019 Jul 9;7(7):500-502. Epub 2019 Jun 9.

Diabetes Center Bochum-Hattingen, St. Josef-Hospital, Ruhr-University Bochum, D-44791 Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(19)30182-2DOI Listing
July 2019

Owning a Dog as a Determinant of Physical Activity and Metabolic Control in Patients With Type 1 and Type 2 Diabetes Mellitus.

Exp Clin Endocrinol Diabetes 2019 Jun 27. Epub 2019 Jun 27.

Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0890-3254DOI Listing
June 2019

GIP and GLP-1: Stepsiblings Rather Than Monozygotic Twins Within the Incretin Family.

Diabetes 2019 May;68(5):897-900

Diabetes Center Bochum-Hattingen, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dbi19-0005DOI Listing
May 2019

Health-related quality of life in people with type 2 diabetes participating in the LEADER trial.

Diabetes Obes Metab 2019 03 25;21(3):525-532. Epub 2018 Oct 25.

Nuffield Department of Population Health, Health Economics Research Centre, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587748PMC
March 2019

Liraglutide and Glycaemic Outcomes in the LEADER Trial.

Diabetes Ther 2018 Dec 3;9(6):2383-2392. Epub 2018 Nov 3.

University of North Carolina School of Medicine, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13300-018-0524-z
Publisher Site
http://dx.doi.org/10.1007/s13300-018-0524-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250637PMC
December 2018

Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus.

Int J Clin Pract 2018 Oct;72(10):e13240

Diabetes Research Centre, University of Leicester, Leicester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijcp.13240DOI Listing
October 2018

Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial).

Am J Cardiol 2018 06 15;121(12):1467-1470. Epub 2018 Mar 15.

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.02.030DOI Listing
June 2018

Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual Patterns.

Trends Endocrinol Metab 2018 04 17;29(4):238-248. Epub 2018 Feb 17.

Diabetes Center Bochum-Hattingen, Department of Medicine I, St Josef-Hospital (Ruhr-Universität Bochum), Bochum, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tem.2018.01.011DOI Listing
April 2018

Incretin hormones: Their role in health and disease.

Diabetes Obes Metab 2018 02;20 Suppl 1:5-21

Diabetes Center Bochum-Hattingen, Medical Department I, St. Josef-Hospital, Ruhr-University, Bochum, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13129
Publisher Site
http://dx.doi.org/10.1111/dom.13129DOI Listing
February 2018

Break point instead of ACE: acarbose, post-load glycaemic excursions, and cardiovascular events.

Lancet Diabetes Endocrinol 2017 11 13;5(11):843-845. Epub 2017 Sep 13.

Diabetes Center Bochum-Hattingen, Medical Department I, St Josef-Hospital, Ruhr-University Bochum, D-44791 Bochum, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22138587173031
Publisher Site
http://dx.doi.org/10.1016/S2213-8587(17)30318-2DOI Listing
November 2017

Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals.

Diabetes Care 2017 Oct 27;40(10):1314-1322. Epub 2017 Jul 27.

Diabetes Division, Department of Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/lookup/doi/10.2337/dc17-079
Publisher Site
http://dx.doi.org/10.2337/dc17-0792DOI Listing
October 2017

A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite.

Am J Physiol Endocrinol Metab 2017 09 18;313(3):E284-E291. Epub 2017 Apr 18.

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpendo.00005.2017DOI Listing
September 2017

Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio-vascular outcome trials.

Diabetes Obes Metab 2017 09 22;19(9):1327-1328. Epub 2017 May 22.

Department of Medicine I, St. Josef-Hospital (Ruhr-University Bochum), Bochum, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.12981
Publisher Site
http://dx.doi.org/10.1111/dom.12981DOI Listing
September 2017

Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy.

Diabetes Res Clin Pract 2017 Sep 15;131:49-60. Epub 2017 Jun 15.

Division of Diabetology, Medical Department I, St. Josef-Hospital, Ruhr-Universität, Bochum, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2017.06.013DOI Listing
September 2017

Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.

Circulation 2017 Aug;136(9):849-870

From Diabetes Center Bochum-Hattingen, St Josef-Hospital, Ruhr-University Bochum, Germany (M.A.N., J.J.M., M.A.E.A.); Department of Medicine, University of North Carolina, Chapel Hill (M.A.C.); and Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mt Sinai Hospital, University of Toronto, Ontario, Canada (D.J.D.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028136DOI Listing
August 2017

Efficacy and Safety of GLP-1 Receptor Agonists Across the Spectrum of Type 2 Diabetes Mellitus.

Exp Clin Endocrinol Diabetes 2017 Jul 19;125(7):419-435. Epub 2017 Jul 19.

Division of Diabetology, Medical Department I, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-103969DOI Listing
July 2017

[Why is a combination of basal insulin with a GLP-1 receptor agonist useful in many patients with type 2 diabetes?]

MMW Fortschr Med 2017 06 22;159(Suppl 5):7-15. Epub 2017 Jun 22.

Novo Nordisk Pharma GmbH, Mainz, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15006-017-9803-2DOI Listing
June 2017

Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials.

Diabetes Obes Metab 2017 03 19;19(3):336-347. Epub 2016 Dec 19.

Division of Diabetology, Medical Department I, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.12824
Publisher Site
http://dx.doi.org/10.1111/dom.12824DOI Listing
March 2017

Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes.

Diabetes Obes Metab 2017 02 9;19(2):200-207. Epub 2016 Nov 9.

Department of Biomedical Sciences, Panum Institute, NovoNordisk Foundation Center for Metabolic Research, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12802DOI Listing
February 2017

A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.

Diabetes Obes Metab 2017 02 29;19(2):216-227. Epub 2016 Nov 29.

Division of Diabetology, Department of Internal Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.12804
Publisher Site
http://dx.doi.org/10.1111/dom.12804DOI Listing
February 2017

Sitagliptin plus basal insulin: simplifying in-hospital diabetes treatment?

Lancet Diabetes Endocrinol 2017 02 8;5(2):83-85. Epub 2016 Dec 8.

Division of Diabetology, Medical Department I, St. Josef-Hospital (Ruhr-University Bochum), D-44791 Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(16)30401-6DOI Listing
February 2017

Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies.

Diabetes Obes Metab 2016 12 26;18(12):1253-1262. Epub 2016 Sep 26.

Diabetes Division, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12766DOI Listing
December 2016

GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?

Lancet Diabetes Endocrinol 2016 12 16;4(12):963-964. Epub 2016 Sep 16.

Division of Diabetology, Medical Department I, St Josef Hospital (Ruhr-University Bochum), Bochum D-44791 Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(16)30263-7DOI Listing
December 2016

Diabetes: Incretin mimetics and insulin - closing the gap to normoglycaemia.

Nat Rev Endocrinol 2016 11;12(12):689-690

Division of Diabetology, Department of Medicine, St Josef-Hospital, Ruhr University Bochum, Gudrunstraße 56, D-44791, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2016.180DOI Listing
November 2016

Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial.

Diabetes Care 2016 Sep 16;39(9):1501-9. Epub 2016 Jun 16.

Department of Endocrinology, l'Institut du Thorax, Nantes University Hospital, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc15-2479DOI Listing
September 2016

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2016 07 13;375(4):311-22. Epub 2016 Jun 13.

From the University of Texas Southwestern Medical Center, Dallas (S.P.M.); Massachusetts General Hospital, Boston (G.H.D.); Novo Nordisk, Bagsvaerd, Denmark (K.B.-F., P.K., L.S.R., M.S.); Friedrich Alexander University of Erlangen, Erlangen (J.F.E.M.), and St. Josef Hospital, Ruhr University, Bochum (M.A.N.) - both in Germany; Cleveland Clinic, Cleveland (S.E.N.); London School of Hygiene and Tropical Medicine Medical Statistics Unit (S.P.) and Imperial College London (N.R.P.), London; George Washington University Medical Center, Washington, DC (W.M.S.); Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto (B.Z.); International Diabetes Center at Park Nicollet, Minneapolis (R.M.B.); and the University of North Carolina School of Medicine, Chapel Hill (J.B.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1603827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985288PMC
July 2016

The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions.

Lancet Diabetes Endocrinol 2016 06 12;4(6):525-36. Epub 2016 Feb 12.

Diabetes Division, Department of Medicine I, St Josef Hospital (Ruhr-University Bochum), Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(15)00482-9DOI Listing
June 2016

The insulinotropic effect of pulsatile compared with continuous intravenous delivery of GLP-1.

Diabetologia 2016 May 30;59(5):966-9. Epub 2016 Jan 30.

Discipline of Acute Care Medicine, University of Adelaide, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-016-3878-7DOI Listing
May 2016

Novel approaches to treating type 2 diabetes.

Authors:
Michael A Nauck

Diabetologia 2016 Feb 4;59(2):227-8. Epub 2015 Dec 4.

Division of Diabetology, St. Josef-Hospital (Ruhr-University Bochum), Gudrunstr. 56, D-44791, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-015-3823-1DOI Listing
February 2016

Incretin-based therapies: where will we be 50 years from now?

Diabetologia 2015 Aug 21;58(8):1745-50. Epub 2015 May 21.

Division of Diabetes and GI Endocrinology, University Hospital St Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-015-3608-6DOI Listing
August 2015

GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial.

Diabetologia 2015 Aug 21;58(8):1759-68. Epub 2015 May 21.

Department of Clinical Nutrition, German Institute of Human Nutrition, Potsdam-Rehbruecke, Arthur-Scheunert-Allee 155, 14558, Nuthetal, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-015-3618-4DOI Listing
August 2015

Update on developments with SGLT2 inhibitors in the management of type 2 diabetes.

Authors:
Michael A Nauck

Drug Des Devel Ther 2014 11;8:1335-80. Epub 2014 Sep 11.

Department of Internal Medicine, Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany.

View Article

Download full-text PDF

Source
http://www.dovepress.com/update-on-developments-with-sglt2-i
Publisher Site
http://dx.doi.org/10.2147/DDDT.S50773DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166348PMC
July 2015

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Diabetes Care 2015 Jan;38(1):140-9

Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, U.K. National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, Oxford, U.K. Harris Manchester College, University of Oxford, Oxford, U.K.

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/content/38/1/140.full.pdf+h
Web Search
http://care.diabetesjournals.org/content/38/1/140.full.pdf
Web Search
http://care.diabetesjournals.org/lookup/doi/10.2337/dc14-244
Publisher Site
http://dx.doi.org/10.2337/dc14-2441DOI Listing
January 2015

Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance.

Diabetes Care 2015 Jan;38(1):e7-8

Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany Department of Endocrinology, Diabetes and Nutrition, Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-1452DOI Listing
January 2015

LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial.

Pancreas 2014 Nov;43(8):1223-31

From the *Department of Medicine, George Washington University Medical Center, Rockville, MD; †Department of Internal Medicine/Diabetology, Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany; ‡Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; §Thyroid Unit and Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, MA; ║Park Nicollet Institute for Research and Education, International Diabetes Center, Minneapolis, MN; ¶Department of Medicine, Friedrich Alexander University of Erlangen, Erlangen, Germany; #Novo Nordisk, A/S, Bagsvaerd, Denmark; **Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX; and ††Division of Endocrinology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206347PMC
November 2014

Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.

Diabetes Care 2014 Oct 10;37(10):2763-73. Epub 2014 Jul 10.

Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/lookup/doi/10.2337/dc14-087
Publisher Site
http://dx.doi.org/10.2337/dc14-0876DOI Listing
October 2014

Risk of pancreatitis in patients treated with incretin-based therapies.

Diabetologia 2014 Jul 11;57(7):1320-4. Epub 2014 Apr 11.

Diabetes Division, Department of Medicine I, St Josef-Hospital, Ruhr-University of Bochum, Gudrunstrasse 56, 44791, Bochum, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-014-3231-yDOI Listing
July 2014

Studying pancreatic risks caused by incretin-based therapies: is it a game? It's not a game!

J Diabetes Sci Technol 2014 Jul 12;8(4):895-7. Epub 2014 May 12.

Department of Diabetology and Gastrointestinal Endocrinology, Medizinische Klinik 1, St. Josef-Hospital, Klinikum der Ruhr-Universität Bochum, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1932296814532874DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764228PMC
July 2014

A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.

Diabetologia 2014 May 21;57(5):868-77. Epub 2014 Jan 21.

Diabeteszentrum Bad Lauterberg, Kirchberg 21, 37431, Bad Lauterberg im Harz, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-014-3168-1DOI Listing
May 2014

Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose.

Diabetes 2014 Feb 1;63(2):663-74. Epub 2013 Nov 1.

Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db13-0805DOI Listing
February 2014

Pancreatitis and incretin-based drugs: clarity or confusion?

Lancet Diabetes Endocrinol 2014 Feb 12;2(2):92-3. Epub 2013 Nov 12.

Division of Diabetology and Gastrointestinal Endocrinology, St Josef-Hospital, University Hospital, Ruhr University, Bochum, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(13)70186-4DOI Listing
February 2014

Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.

Metabolism 2013 Sep 4;62(9):1330-9. Epub 2013 Jul 4.

Institute of Clinical Physiology, National Research Council, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2013.05.001DOI Listing
September 2013

Do GLP-1-based therapies increase cancer risk?

Diabetes Care 2013 Aug;36 Suppl 2:S245-52

Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Harz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dcS13-2004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920789PMC
August 2013

A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks.

Authors:
Michael A Nauck

Diabetes Care 2013 Jul 3;36(7):2126-32. Epub 2013 May 3.

Diabetes Center, Bad Lauterberg, Bad Lauterberg im Harz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc12-2504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687264PMC
July 2013

Author reply: To PMID 23208166.

Ann Intern Med 2013 Mar;158(6):501-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00021DOI Listing
March 2013

Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.

Ann Intern Med 2012 Dec;157(11):767-75

Diabeteszentrum Bad Lauterberg, Kirchberg 21, D-37431 Bad Lauterberg im Harz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00004DOI Listing
December 2012

In vivo effect of glucose-dependent insulinotropic peptide (GIP) on the gene expression of calcitonin peptides in human subcutaneous adipose tissue.

Regul Pept 2012 Nov 5;179(1-3):29-32. Epub 2012 Sep 5.

Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.regpep.2012.08.004DOI Listing
November 2012

[Type 2 diabetes: Which long-acting insulin should be preferred?].

Authors:
Michael Nauck

Dtsch Med Wochenschr 2012 Aug 14;137(34-35):1678. Epub 2012 Aug 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0032-1301867DOI Listing
August 2012

Chronic reduction of fasting glycemia with insulin glargine improves first- and second-phase insulin secretion in patients with type 2 diabetes.

Diabetes Care 2011 Sep 20;34(9):2048-53. Epub 2011 Jul 20.

Department of Medicine I, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc11-0471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161280PMC
September 2011

Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials.

J Clin Endocrinol Metab 2011 Jun 30;96(6):1695-702. Epub 2011 Mar 30.

Division of Endocrinology, University of North Carolina School of Medicine, CB 7172, 8027 Burnett-Womack Building, Chapel Hill, North Carolina 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2010-2822DOI Listing
June 2011

Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.

Diabetes 2011 May 23;60(5):1561-5. Epub 2011 Mar 23.

Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db10-0474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292331PMC
May 2011

Pharmacotherapy: GLP-1 analogues and insulin: sound the wedding bells?

Nat Rev Endocrinol 2011 Apr 22;7(4):193-5. Epub 2011 Feb 22.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrendo.2011.30
Publisher Site
http://dx.doi.org/10.1038/nrendo.2011.30DOI Listing
April 2011

Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.

Authors:
Michael A Nauck

Am J Med 2011 Jan;124(1 Suppl):S3-18

Bad Lauterberg Diabetes Center, Bad Lauterberg im Harz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2010.11.002DOI Listing
January 2011

Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic beta-cell area.

Eur J Endocrinol 2010 Oct 2;163(4):551-8. Epub 2010 Aug 2.

Department of Medicine I, St Josef-Hospital, Ruhr-University Bochum, Gudrunstrasse 56, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-10-0330DOI Listing
October 2010

Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans.

J Clin Endocrinol Metab 2010 Aug 25;95(8):4061-5. Epub 2010 May 25.

Department of Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstrasse 56, 44791 Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2010-0550DOI Listing
August 2010

Individualised incretin-based treatment for type 2 diabetes.

Lancet 2010 Aug 26;376(9739):393-4. Epub 2010 Jun 26.

Diabeteszentrum Bad Lauterberg, D-37431 Bad Lauterberg im Harz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)60998-1DOI Listing
August 2010

Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies.

Am J Med 2010 Jul;123(7):S2-S10

Tulane University Health Sciences Center, New Orleans, Louisiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2010.04.002DOI Listing
July 2010